CompanyDrug

Antengene Launches Phase I CLINCH Study for ATG-022 in Australia

CompanyDrug

Henlius Begins Phase I Trial for Biosimilar HLX15 Targeting Multiple Myeloma

CompanyDeals

NeuShen Therapeutics Partners with UMass Chan for ALS Gene Therapy Development

CompanyDeals

F-Star Therapeutics and Sino Biopharmaceutical Seek CFIUS Approval with Extended Deadline

CompanyDrug

Jiangsu Hengrui’s SHR8058 Accepted for Review by China’s NMPA for Dry Eye Disease

CompanyDrug

Nanjing-Based Frontier Biotechnologies Secures Full Approval for Albuvirtide in China

CompanyDrug

Junshi Biosciences’ JS401 Accepted for Review by China’s NMPA for Hyperlipidemia

Company

Pfizer Reports Record Revenues as COVID-19 Sales Soar; 2023 Guidance Amid Market Shifts

CompanyDeals

Junshi Biosciences Partners with Huahai for Production of COVID-19 Drug VV116

CompanyDrug

Ocumension Completes Enrollment for Global Phase III Study of Myopia Treatment OT-101

CompanyDeals

R&B Bio Raises RMB 200 Million in Series A+ Round to Advance Gene Therapy Pipeline

CompanyDrug

Hengrui’s HER2-Targeted ADC SHR-A1811 Gains NMPA Clearance for Clinical Trial